Regions Financial Corp Neogenomics Inc Transaction History

Regions Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 27, 2020	SELL	$24.21 - $31.02 $267,278 - $342,460	-11,040 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$20.5 - $34.53 $32,062 - $54,004	-1,564 Reduced 12.41%	11,040 $305,000
Q4 2019 Feb 03, 2020	BUY	$18.96 - $29.84 $777 - $1,223	41 Added 0.33%	12,604 $369,000
Q3 2019 Oct 24, 2019	BUY	$19.12 - $26.24 $1,395 - $1,915	73 Added 0.58%	12,563 $240,000
Q2 2019 Jul 19, 2019	BUY	$19.57 - $24.1 $244,429 - $301,009	12,490 New	12,490 $274,000
Q3 2018 Oct 22, 2018	SELL	$12.5 - $15.38 $225,000 - $276,840	-18,000 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$7.99 - $14.05 $6,008 - $10,565	-752 Reduced 4.01%	18,000 $236,000
Q4 2017 Jan 18, 2018	SELL	$8.02 - $11.18 $24,060 - $33,540	-3,000 Reduced 13.79%	18,752 $166,000
Q3 2017 Oct 23, 2017	BUY	$9.11 - $11.26 $198,160 - $244,927	21,752	21,752 $242,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.83B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.